Caption Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,240
Closed -$5.63M 1841
2025
Q4
$5.63M Buy
+5,240
New +$5.01M 0.04% 484
2025
Q3
Sell
-5,300
Closed -$4.13M 1875
2025
Q2
$4.13M Buy
+5,300
New +$4.12M 0.05% 455
2024
Q1
Sell
-11,700
Closed -$6.82M 1462
2023
Q4
$6.82M Buy
+11,700
New +$6.83M 0.09% 258
2022
Q4
Sell
-237
Closed -$77K 1513
2022
Q3
$77K Buy
+237
New +$75.1K ﹤0.01% 1358
2021
Q2
Sell
-12,000
Closed -$2.24M 1456
2021
Q1
$2.24M Buy
+12,000
New +$2.35M 0.05% 485
2018
Q2
Sell
-10,000
Closed -$773K 421
2018
Q1
$773K Buy
+10,000
New +$805K 0.11% 170

Other funds holding LLY

Caption Management's LLY Position: Q1 2026 in Review

Caption Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 5,240 shares — an estimated $5.63M sold.

Caption Management first reported a position in LLY in Q1 2018 and held it in 6 quarters. The position peaked at $6.82M in Q4 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Caption Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 5,240 Eli Lilly shares in Q1 2026, an estimated $5.63M.
  • Caption Management first reported a position in Eli Lilly in Q1 2018 and held it in 6 quarters.
  • Caption Management's Eli Lilly position peaked at $6.82M in Q4 2023.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.